Skip to main content
. Author manuscript; available in PMC: 2018 Dec 5.
Published in final edited form as: Inorg Chem. 2018 Feb 21;57(5):2333–2350. doi: 10.1021/acs.inorgchem.7b02912

Figure 14.

Figure 14

A. The cRGD peptide-labeled, Gd3+-DOTA chelates-carrying dodecaborate cluster MRI contrast agent and B. the resulting strong contrast enhancement in T1-weighted MRI scans of mice for up to 4 hours after injection. Reprinted (adapted) with permission from Goswami, L. N.; Ma, L.; Cai, Q.; Sarma, S. J.; Jalisatgi, S. S.; Hawthorne, M. F. Inorg. Chem. 2013, 52, 1701. Copyright 2013 American Chemical Society.